Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells.
Michael HajekWendell G YarbroughAndrew SewellCyril GaryPaul CantalupoKaren S AndersonWendell G YarbroughNatalia IssaevaPublished in: Cancers (2020)
High levels of DNA methylation at CpG loci are associated with transcriptional repression of tumor suppressor genes and dysregulation of DNA repair genes. Human papilloma virus (HPV)-associated head and neck squamous cell carcinomas (HNSCC) have high levels of DNA methylation and methylation has been associated with dampening of an innate immune response in virally infected cells. We have been exploring demethylation as a potential treatment in HPV+ HNSCC and recently reported results of a window clinical trial showing that HNSCCs are particularly sensitive to demethylating agent 5-azacytidine (5-aza). Mechanistically, sensitivity is partially due to downregulation of HPV genes expression and restoration of tumor suppressors p53 and Rb. Here, for the first time, we show that 5-azaC treatment of HPV+ HNSCC induces replication and transcription-associated DNA double strand breaks (DSBs) that occur preferentially at demethylated genomic DNA. Blocking replication or transcription prevented formation of DNA DSBs and reduced sensitivity of HPV-positive head and neck cancer cells to 5-azaC, demonstrating that both replication and active transcription are required for formation of DSBs associated with 5-azaC.
Keyphrases
- genome wide
- dna methylation
- high grade
- immune response
- circulating tumor
- transcription factor
- dna repair
- clinical trial
- cell free
- gene expression
- single molecule
- cervical cancer screening
- copy number
- dna damage
- squamous cell
- endothelial cells
- nucleic acid
- genome wide identification
- signaling pathway
- oxidative stress
- cell proliferation
- dendritic cells
- open label
- toll like receptor
- phase ii
- risk assessment
- combination therapy
- long non coding rna
- binding protein
- phase iii
- induced pluripotent stem cells
- double blind
- genome wide analysis